Anergic TH1 clones specific for hepatitis B virus (HBV) core peptides are inhibitory to other HBV core-specific CD4+ T cells in vitro.

H M Diepolder; M C Jung; E Wierenga; R M Hoffmann; R Zachoval; T J Gerlach; S Scholz; G Heavner; G Riethmüller; G R Pape

doi:10.1128/JVI.70.11.7540-7548.1996

Anergic TH1 clones specific for hepatitis B virus (HBV) core peptides are inhibitory to other HBV core-specific CD4+ T cells in vitro.

Identifier:nobleid.org/w1/20260515/54972DBB

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/54972DBB.svg?ark=w1%2F20260515%2F54972DBB)](https://nobleid.org/work/w1/20260515/54972DBB)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Anergic TH1 clones specific for hepatitis B virus (HBV) core peptides are inhibitory to other HBV core-specific CD4+ T cells in vitro.

Identifier:nobleid.org/w1/20260515/54972DBB

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/54972DBB.svg?ark=w1%2F20260515%2F54972DBB)](https://nobleid.org/work/w1/20260515/54972DBB)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work